×
About 11,517,712 results

Infigratinib Demonstrates Clinical Activity Across Settings in Urothelial Cancer
https://www.onclive.com/view/infigratinib-demonstrates-clinical-activity-across-settings-in-urothelial-cancer

May 31st, 2020

Alectinib Continues to Maintain Significant OS Benefit in ALK+ NSCLC
https://www.onclive.com/view/alectinib-continues-to-maintain-significant-os-benefit-in-emalkem-nsclc

May 30th, 2020

Tepotinib Displays Durable Clinical Benefit in METex14-Altered NSCLC
https://www.onclive.com/view/tepotinib-displays-durable-clinical-benefit-in-metex14altered-nsclc

May 30th, 2020

Pralsetinib Active Across RET+ Tumor Types and Gains FDA Review
https://www.onclive.com/view/pralsetinib-active-across-emretem-tumor-types-and-gains-fda-review-

May 31st, 2020

Dr. Plimack on Updated Findings of the KEYNOTE-426 Study in RCC
https://www.onclive.com/view/dr-plimack-on-updated-findings-of-the-keynote426-study-in-rcc

May 31st, 2020

MGD013 Demonstrates Encouraging Activity Across Tumor Types
https://www.onclive.com/view/mgd013-demonstrates-encouraging-activity-across-tumor-types

May 31st, 2020

TRK Inhibitor Continues to Show Multi-Cancer Effects
https://www.medpagetoday.com/meetingcoverage/asco/86834

Jun 1st, 2020

Early Palliation: Boon for AML Patients on Intensive Chemo
https://www.medpagetoday.com/meetingcoverage/asco/86820

Jun 1st, 2020

Autologous TILs Active in Refractory Melanoma
https://www.medpagetoday.com/meetingcoverage/asco/86840

Jun 1st, 2020

Hydroxychloroquine, Azithromycin Combo Risky for Cancer Patients
https://www.medpagetoday.com/meetingcoverage/ascovideopearls/87062

Jun 14th, 2020

Newly Diagnosed MM: RVd Still Standard of Care
https://www.medpagetoday.com/meetingcoverage/ascovideopearlsmm/87038

Jun 11th, 2020

High Marks for CAR T Cells in R/R Myeloma
https://www.medpagetoday.com/meetingcoverage/asco/86858

Jun 2nd, 2020

Second Surgery Gets OS Win in Recurrent Ovarian Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86836

Jun 1st, 2020

Dr. Gwin on the Mechanism of Action of Alpha-TEA in HER2-Positive Metastatic Breast Cancer
https://www.onclive.com/view/dr-gwin-on-the-mechanism-of-action-of-alphatea-in-her2positive-metastatic-breast-cancer

Jun 4th, 2020

Dr. Mascarenhas on the Impact of Ruxolitinib on the Myelofibrosis Treatment Paradigm
https://www.onclive.com/view/dr-mascarenhas-on-the-impact-of-ruxolitinib-on-the-myelofibrosis-treatment-paradigm

Jun 4th, 2020

Surgery for Metastatic Breast Cancer Fails to Boost Overall Survival
https://www.medpagetoday.com/meetingcoverage/asco/86802

May 31st, 2020

Pembrolizumab May Help in Triple-Negative Breast Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86804

May 31st, 2020

PTSD Symptoms Common in Stem Cell Recipients
https://www.medpagetoday.com/meetingcoverage/asco/86811

May 31st, 2020

Dr. Rodriguez-Abreu on Updated Results From the KEYNOTE-189 Trial in NSCLC
https://www.onclive.com/view/dr-rodriguezabreu-on-updated-results-from-the-keynote189-trial-in-nsclc

Jun 4th, 2020

Dr. Wolf on Updated Findings With Capmatinib in METex14-Mutant NSCLC
https://www.onclive.com/view/dr-wolf-on-updated-findings-with-capmatinib-in-metex14mutant-nsclc

Jun 2nd, 2020